CCL23 and fatty liver disease: The plasma level of CCL23 has also been associated with plasma oxidative low‐density lipoprotein (Kim et al, 2011a), which could affect the redox balance in hepatic cells, and the latter has been linked to hepatic steatosis in recent studies (Walenbergh et al, 2013).